Clinical Trial Update: Pharmacokinetic Study Comparing Budesonide/Formoterol Easyhaler and Symbicort Turbuhaler Forte [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic study comparing budesonide/formoterol delivered by Easyhaler versus Symbicort Turbuhaler Forte in asthma; the study is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Budesonide/Formoterol Easyhaler (budesonide/formoterol)
• Symbicort Turbuhaler Forte (budesonide/formoterol)

Snippet

Sponsor: Orion Corporation, Orion Pharma | Conditions: Asthma | Phase 1 | Status: COMPLETED